The SIGN guidelines 174 re port uncertainty about the role of aspirin in primary prevention. Citing the HOT study (a randomised controlled trial) and the further reduction in arterial risk in well-controlled hypertensive patients with diabetes, they note the importance of balancing this reduction against the risk of bleeding
---
 nice.evidencecategory: Ia
[@Linden_2011]
